How this man survived brain cancer with a 0% survival rate - EP43
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
We flew to Ontario to meet Steve Allgood, the 2nd patient in Canadian history to receive psychedelic assisted therapy through the health care system.We can't even begin to imagine being diagnosed with cancer just days before your wedding, and not just any cancer, one that almost nobody survives.Steve has come a long way since then, defying all odds and still alive today to share his story, with his beautiful wife and two kids.If you are moved by his story - WRITE A LETTER TO YOUR MP: https://therapsil.ca/get-involved/More details:7 and a half years ago, Steve was diagnosed with terminal brain cancer just two days before his wedding. The diagnosis was DIPG, diffuse intrinsic pontine glioma, a rare and aggressive pontine glioma located on the brainstem tumour near the pons tumor area. Doctors in oncology and neuro-oncology gave him a terminal diagnosis with zero percent chance of survival. He was told to go home and prepare for the worst.Instead of accepting that, Steve started his own cancer journey. After radiation therapy, he was offered chemotherapy, but began exploring alternative treatment options. He connected with long-term cancer survival stories online and discovered complementary medicine approaches like high-dose cannabis, cannabis oil, and Rick Simpson Oil (RSO). Medical marijuana became a major part of his protocol, along with vitamin C IV therapy, nutrition and cancer research, sugar-free diet changes, and overall lifestyle change focused on reducing inflammation and immune system rebuilding. These integrative medicine and functional medicine approaches challenged everything he thought he knew about the Canadian healthcare system.Steve also became the 2nd patient in Canadian history to legally access psilocybin therapy through Health Canada's Section 56 exemption and Special Access Program. His experience with psilocybin-assisted therapy helped him process deep trauma healing, PTSD, grief, anxiety, and depression. Through guided trip sessions with proper set and setting and a trip sitter, followed by integration therapy and psychotherapy, Steve experienced a spiritual awakening, going from atheism to spirituality. The therapy helped with acceptance of the unknown, meaning-making, life review, and neuroplasticity changes that reshaped how he sees the world.We also talked about his experience with MDMA therapy, his thoughts on microdosing, and why he's become a voice for psychedelic advocacy in Canada. Steve now advocates for patient rights, patient advocacy, informed consent, and healthcare reform. He's critical of how cancer charities operate and passionate about harm reduction and mental health advocacy.Beyond the medical side, Steve opened up about the family impact of his diagnosis, the wedding diagnosis story, fatherhood challenges, and how his wife and mother-in-law pushed him to fight. His story also touches on broader issues like Vancouver mental health, corrections system trauma, and community healing.Steve's been featured on Cannabis Health Radio and is part of an upcoming documentary interview. He continues to get MRI scans and remains in palliative care monitoring, but his tumor has been stable for years. He's living proof of what long-term cancer survival can look like when you explore every option.His message is simple: question everything, advocate for yourself, and don't be afraid to look beyond conventional cancer support. Whether it's blood-brain barrier research, advocacy for legalization, or just learning about brainstem tumour treatments like glioma and pons tumour cases, there's more out there than most people realize.Diagnosed with terminal brain cancer just before his wedding, this individual shares his compelling brain tumour story. Given no chance of survival, he advocates for medical cannabis and psilocybin therapy as alternative cancer treatment options. His experience sheds light on the difficult choices cancer patients face beyond traditional chemotherapy.